HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CRIPTO-1: a novel target for therapeutic intervention in human carcinoma.

Abstract
Evidence suggests that CRIPTO-1 (CR-1) might be involved in the pathogenesis of human carcinoma. In the present study, we have screened the expression of CR-1 mRNA and protein in a wide panel of human cancer cell lines by using reverse transcriptase (RT)-PCR, real-time PCR and immunocytochemistry. Results of these experiments demonstrate that CR-1 is expressed in several, different carcinoma types. The anchorage-independent growth of colon, ovarian, lung and breast carcinoma cells was significantly inhibited by treatment with anti-CR-1 second generation antisense oligonucleotides. Similar results were obtained with anti-transforming growth factor alpha (TGF-alpha) and anti-amphiregulin (AR) antisense oligonucleotides. Treatment of carcinoma cells with CR-1 antisense oligonucleotides resulted in a significant reduction in the levels of expression of CR-1 mRNA and protein, and in the levels of activation of Akt. Finally, oral administration of either CR-1, AR or TGF-alpha antisense oligonucleotides produced a significant reduction in the growth of GEO colon carcinoma xenografts in nude mice that was associated with a reduction in the levels of expression of the target proteins. Taken together, these data strongly suggest that CR-1 might represent a novel target for therapeutic intervention in different carcinoma types.
AuthorsNicola Normanno, Antonella De Luca, Monica R Maiello, Caterina Bianco, Mario Mancino, Luigi Strizzi, Claudio Arra, Fortunato Ciardiello, Sudhir Agrawal, David S Salomon
JournalInternational journal of oncology (Int J Oncol) Vol. 25 Issue 4 Pg. 1013-20 (Oct 2004) ISSN: 1019-6439 [Print] Greece
PMID15375551 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • AREG protein, human
  • Amphiregulin
  • Areg protein, mouse
  • EGF Family of Proteins
  • GPI-Linked Proteins
  • Glycoproteins
  • Intercellular Signaling Peptides and Proteins
  • Membrane Glycoproteins
  • Neoplasm Proteins
  • Oligonucleotides, Antisense
  • RNA, Messenger
  • TDGF1 protein, human
  • Transforming Growth Factor alpha
  • Epidermal Growth Factor
Topics
  • Amphiregulin
  • Animals
  • Cell Line, Tumor
  • EGF Family of Proteins
  • Epidermal Growth Factor (antagonists & inhibitors, genetics)
  • GPI-Linked Proteins
  • Glycoproteins (antagonists & inhibitors)
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Membrane Glycoproteins (antagonists & inhibitors, genetics)
  • Mice
  • Neoplasm Proteins (antagonists & inhibitors, genetics)
  • Neoplasms (therapy)
  • Oligonucleotides, Antisense (pharmacology, therapeutic use)
  • RNA, Messenger (analysis)
  • Transforming Growth Factor alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: